Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

ReLive Biotechnologies Acquires Co.Don AG, Secures USD 36 Million for Expansion

January 24, 2025
CompanyDrug

Akeso’s Penpulimab Secures New Approval for Lung Cancer Indication

January 24, 2025
CompanyDrug

Clover Biopharmaceuticals Plans COVID-19 Vaccine SCB-2019 Launch in China for 2023

January 24, 2025
CompanyDrug

Amoytop’s AK0706 Receives Clinical Trial Approval for Hepatitis B Treatment

January 24, 2025
CompanyDeals

JHM Biopharma Raises RMB100 Million to Expand Protein Drug Pipeline

January 24, 2025
CompanyDrug

Sino Biopharma’s PD-L1 Combo with Anlotinib Accepted for Review by China’s CDE

January 24, 2025
CompanyDeals

Meheco’s Genertec Partners with AstraZeneca for COVID-19 Antibody Evusheld in China

January 24, 2025
CompanyDrug

Guangzhou’s Overseas Pharma Wins China Clinical Trial Approval for OPL-038

January 24, 2025
CompanyDeals

Eyougene Raises Hundreds of Millions in Series B Funding for Expansion

January 25, 2025
CompanyDeals

LePure Bio Secures Hundreds of Millions in Series C Funding for Expansion

January 24, 2025
CompanyDeals

Shenzhen Keyto Fluid Control Secures Series C Funding for Expansion

January 24, 2025
CompanyDrug

Xinhua Pharma’s OAB-14 Receives NMPA Approval for Phase I Alzheimer’s Study

January 24, 2025
1 2 … 7 8 9 10 11 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up